Showing 1 - 10 of 765
Background: Fragility fracture related to osteoporosis among postmenopausal women is a significant cause of morbidity. The care and aftercare of these fractures are associated with substantial costs to society. A main problem is that many individuals suffer from osteoporosis without knowing it...
Persistent link: https://www.econbiz.de/10014489841
Background and Objective: Despite the importance of medication adherence for chronically ill patients and the vast literature on its relationship to costs, this field suffers from methodological limitations. These are caused, amongst others, by the lack of generalizability of data sources,...
Persistent link: https://www.econbiz.de/10015191348
Objective: We examined the effects of fixe-dose combinations (FDCs) versus loose-dose combinations (LDCs) on costs from the payer and patient perspective and investigated potential channels contributing to differences in costs between the two modes of treatment. Methods We investigated...
Persistent link: https://www.econbiz.de/10015191369
Persistent link: https://www.econbiz.de/10015191381
Background: High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings. This study aimed to evaluate the cost-effectiveness of early...
Persistent link: https://www.econbiz.de/10014489891
Introduction Research on clinical practice guidelines as a determinant of the diffusion of medical technology remains sparse. We aim to evaluate the impact of guidelines on the awareness of medical technology, as a proxy of its use, with the example of cardiac resynchronization therapy (CRT) in...
Persistent link: https://www.econbiz.de/10014497485
Persistent link: https://www.econbiz.de/10014497506
Persistent link: https://www.econbiz.de/10014497528
economic implications of implementing LCIs in state Medicaid programs. Methods We compared LCIs modeled after the intervention …/QALY and US$34 k/QALY; over 25 years, the intervention dominates routine care. The 5-, 10-, and 25-year probabilities that the …
Persistent link: https://www.econbiz.de/10014497533
Background: A trade-off exists between affordability of pharmaceutical products today and incentives for firms to provide new and better drugs in the future; an activity that prior studies suggest correlates with profitability, which in turn depends on price regulation. Objective In this paper we...
Persistent link: https://www.econbiz.de/10014497536